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ABSTRACT Sphingosine 1-phosphate (S1P) is a potent chemokinetic agent for endothelial cells that is released by activated
platelets. We previously developed Arg-Gly-Asp (RGD)-containing polyethylene glycol biomaterials for the controlled delivery of
S1P to promote endothelialization. Here, we studied the effects of cell adhesion strength on S1P-stimulated endothelial cell
migration in the presence of arterial levels of ﬂuid shear stress, since an upward shift in optimal cell adhesion strengths may be
beneﬁcial for promoting long-term cell adhesion to materials. Two RGD peptides with different integrin-binding speciﬁcities were
added to the polyethylene glycol hydrogels. A linear RGD bound primarily to b3 integrins, whereas a cyclic RGD bound through
both b1 and b3 integrins. We observed increased focal adhesion formation and better long-term adhesion in ﬂow with end-
othelial cells on linear RGD peptide, versus cyclic RGD, even though initial adhesion strengths were higher for cells on cyclic
RGD. Addition of 100 nM S1P increased cell speed and random motility coefﬁcients on both RGD peptides, with the largest
increases found on cyclic RGD. For both peptides, much of the increase in cell migration speed was found for smaller cells
(,1522 mm2 projected area), although the large increases on cyclic RGD were also due to medium-sized cells (2288–3519
mm2). Overall, a compromise between high cell migration rates and long-term adhesion will be important in the design of
materials that endothelialize after implantation.
INTRODUCTION
Endothelial cells provide a thrombosis-resistant interface with
the blood, thereby inhibiting pathological cardiovascular events
(1,2). The endothelium can be damaged during cardiovascular
surgical procedures, such as balloon angioplasty, however (3).
Exposure of the matrix underlying the endothelial monolayer
causes remodeling of the matrix and resulting smooth muscle
cell migration that may lead to restenosis (4,5). Implantation of
a stent decreases restenosis rates (6,7), but failure of the implant
due to in-stent restenosis may still occur (8), and late-term
thrombosis rates may be signiﬁcantly higher (9,10). Quick
restoration of an intact endotheliummay improve the long-term
patency of the stents (11,12). Previous investigations have
shown that promoters of endothelial cell migration accelerated
endothelialization of stents, leading to a reduction in thrombo-
sis (13).
Sphingosine 1-phosphate (S1P) is a potent chemokinetic
factor (14), and we have shown that controlled release of S1P
promotes endothelial cell migration on biomaterials (15).
S1P is a vital regulator of endothelial layer barrier integrity
and vascular stabilization (16–18) and inhibits smooth
muscle cell migration at physiological concentrations (19).
However, the rate of endothelialization will also depend on
the interactions of endothelial cells with the biomaterial
substrate, which inﬂuence cell adhesion and motility.
Currently, the dependence of S1P-induced migration on
adhesive properties of a substrate is not known.
The strength of interaction of endothelial cells with a
substrate is critical for motility of the cells. Previous results
from both experiments and mathematical modeling have
shown that cell migration rates have a biphasic dependence
on the concentration of adhesive ligands and the cell at-
tachment strength (20–23). Migration requires sufﬁcient at-
tachment strength to allow traction for the cells to pull
themselves forward, but not so much strength that the rear
edge of the cells can not release. Even when changing the
cell/substrate interactions via ligand type, ligand density,
ligand afﬁnity, or integrin expression, a major controlling
factor of cell migration has been found to be the strength of
cell adhesion to the surface (21,24).
We wished to produce polyethylene glycol (PEG) hydro-
gels with an Arg-Gly-Asp (RGD) concentration that allowed
for maximal endothelial cell migration and adhesion in the
presence of S1P and maximal adhesion in the absence of S1P.
S1P increases endothelial cell migration on a number of
substrates (14,25–33), but the relationship of this molecule to
the adhesiveness of the substrate has not been systematically
explored. In other cell types, growth factors such as EGF
greatly affect the biphasic relationship between cell migration
and strength of cell adhesion to the surface (34). S1P
promotes FAK phosphorylation (29,35) and induces intra-
cellular calcium release (36,37). FAK activation and calcium
have been linked to an increase in adhesion disassembly and
higher focal adhesion turnover (38,39). Because high adhe-
sion strengths may reduce migration rates by preventing the
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release of the rear edge of the cell (20), we hypothesized that
S1P enhances migration even on surfaces with high adhesion
strength. If S1P allowed rapid cell migration at high adhesion
strengths, this might allow for rapid wound healing on a
device, at the same time promoting stable attachment of both
the migrating cells and the ﬁnal endothelial cell monolayer.
We tested linear (40) and cyclic (41) RGD peptides at var-
ious concentrations in the presence of ﬂuid ﬂow and a constant
concentration of S1P. First, we showed that cell adhesion
strength increased with RGD concentration and was stronger
on the cyclic RGD peptide, as expected. We used single-cell
tracking to demonstrate that maximal endothelial cell migration
speeds were obtained with S1P on the cyclic RGD peptide. A
biphasic response was demonstrated for migration speeds on
linear RGD in the absence of S1P. On linear RGD in the
presence of S1P, the highest migration speeds were observed at
the highest RGD concentrations, with no indication of the onset
of a decrease in migration speed at these high RGD
concentrations. This may have indicated that the downslope
of the biphasic response was at a higher RGD concentration
than could be practically added to the gels, although a biphasic
response may also not be present. For cyclic RGD, a relatively
ﬂat response was observed in the absence of S1P, whereas
dramatic increases in cell migration speed were observed in the
presence of S1P. Although we again could not practically add
enough cyclic RGD to observe a downward slope in cell
migration speed, we did observe a dramatic decrease in the
mean random motility coefﬁcient at the highest adhesion
strength versus at intermediate adhesion strengths. Examining
migration speeds as a function of initial cell adhesion strength,
the largest increases in cell migration speed upon addition of
S1P were observed at the higher initial cell adhesion strengths,
effectively shifting the peak in the curve, even if a true biphasic
response was absent. However, high initial cell adhesion
strengths on the cyclic RGD peptide did not lead to higher rates
of retention on the surface over 12 h in the presence of 20 dyn/
cm2 ﬂuid shear stress, indicating a tradeoff between cell
migration speeds and long-term adhesion.
MATERIALS AND METHODS
PEG vinyl sulfone synthesis
PEG-octavinyl sulfone (PEG-OVS) was synthesized from eight-arm PEG
(molecular weight 10,000, Shearwater Polymers, Huntsville, AL) in four
steps, as described previously (15). Brieﬂy, PEG dissolved in toluene was
reacted with methane sulfonyl chloride in the presence of triethylamine
(TEA) to form PEG-mesylate. The PEG-mesylate was dissolved in a sodium
borate buffer and reacted with b-mercaptoethanol at reﬂux in nitrogen to
form PEG-hydroxyethyl sulﬁde. The sulﬁde was oxidized by reaction at 0C
with hydrogen peroxide in distilled water containing sodium tungstate. PEG-
hydroxyethyl sulfone was converted to PEG-vinyl sulfone by reaction with
methane sulfonyl chloride in the presence of TEA. End-group conversion as
shown by NMR was 83%.
Linear RGD peptide preparation
A linear RGD peptide with a single cysteine for coupling to PEG-OVS (Ac-
GCGYGRGDSPG) was synthesized on an ABI 433A peptide synthesizer
(Applied Biosystems, Foster City, CA) using Fmoc chemistry. The peptide
was cleaved for 2 h under nitrogen in 5-mL cleavage cocktail (95%
triﬂuoroacetic acid (TFA), 2.5% triisopropylsilane, 2.5% water) with mixing
every 30 min. The resin was removed by ﬁltration through glass wool
packed in a glass pipette, and the peptide was precipitated in 200 mL ice cold
ether. The peptide was collected by vacuum ﬁltration through a polytetra-
ﬂuoroethylene membrane and dried under vacuum. The RGD peptide was
dissolved in 0.1% TFA in water and puriﬁed by high-performance liquid
chromatography (HPLC) on a C18 column using a gradient of acetonitrile
from 5% to 30% over 30 min. MALDI-TOF mass spectrometry was used to
identify the HPLC fractions containing the product. The peptide fractions
with molecular weight 1067.0 were dried by lyophilization.
Cyclic RGD preparation
The cyclic RGD (Ac-GCNAC*RGDGWC*G) was synthesized on an ABI
433A peptide synthesizer. The second and third cysteines (*) were p-
methoxytrityl (Mmt)-protected, whereas the ﬁrst cysteine was protected by a
trityl (Trt) group. The Mmt protecting groups were selectively removed with
1% TFA while the peptide remained attached to the resin. The peptide was
mixed with 94:1:5 dichloromethane/TFA/triisopropylsilane while bubbling
nitrogen through the solution for 5 min. The solvent was removed and the
selective cleavage was repeated two more times. The peptide was cyclized
by air oxidation, bubbling air through the resin in N-methyl pyrrolidone with
0.1 M TEA. After 3 days of reaction, the solvent was removed by ﬁltration.
Cyclization of the peptide on the resin was conﬁrmed using Ellman’s
reagent, testing for the presence of free thiol groups on the resin. The peptide
was cleaved, puriﬁed, and collected as described for linear RGD above.
After HPLC separation, pure cyclic peptide fractions were identiﬁed using
MALDI to show the reduction of the molecular mass by 2 u from that of the
noncyclized peptide, demonstrating the loss of two protons during the
disulﬁde reaction (see Supplementary Materials, Fig. 1S.) The cyclic RG
peptide has a molecular weight of 1238.3.
Hydrogel functionalization
The linear RGDpeptidewas dissolved at 0.2mg/5mLDulbecco’s phosphate-
buffered saline (DPBS) and the cyclic RGD peptide at 0.232 mg/5 mL
DPBS (137 mM NaCl, 8 mM Na2HPO47 H2O, 0.7 mM CaCl2, 2.7
mM KCl, 1.5 mM KH2PO4, and 0.5 mMMgCl2, pH 7.4). The RGD peptide
was reacted with various fractions of the vinyl sulfone endgroups ranging
from 1/10 to 1/160 (ﬁnal RGD concentrations in the hydrogel of 0.32 mM to
5.5 mM) via the cysteine thiol on the peptide for 30 min at 37C before cross-
linking the PEG hydrogel. Using an Ellman’s assay to detect unreacted
cysteine groups on the RGD peptide, we found complete reaction of thiol
within 5min, even at the highest RGD concentration, as previously described
(42).
Hydrogel formation
Hydrogels were formed by a conjugate addition reaction between PEG-OVS
and fatty acid-free bovine serum albumin (FAF-BSA) (Sigma, St. Louis,
MO). PEG-OVS and FAF-BSA were dissolved in DPBS by adding 10 mg
solid to 50 mL PBS at pH 8.0. All precursors were sterile-ﬁltered. PEG-OVS
was then mixed with FAF-BSA. The optimal ratio of PEG-OVS to FAF-
BSA was determined previously to be 20 mL PEG-OVS (;3.3 mg) to 30 mL
albumin (;5.0 mg) (15).
Cell culture
All cell culture reagents were purchased from Sigma unless otherwise noted.
Human aortic endothelial cells (HAEC) were purchased from Clonetics
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(Walkersville, MD) and cultured in endothelial growth medium (EGM) (MCDB
131 medium) supplemented with 2% fetal bovine serum, 10 ng/mL epidermal
growth factor, 10 mg/mL heparin, 1.0 mg/mL hydrocortisone, 1% antibiotic-
antimycotic (ABAM, 1003) solution (Invitrogen, Carlsbad, CA), and 6 mg/L
bovine brain extract (Clonetics). HAEC were cultured in EGM in six-well tissue
culture plates and cells from passages 4–9 were used for experiments.
Setup for tracking of endothelial cells under ﬂow
Glass microscope slides (24 3 60 mm) were cleaned with 1 mM HCl in a
110C oven overnight. The slides were washed with water and allowed to
dry. Then the slides were silanated in 5% 3-mercaptopropyltrimethoxy
silane (Gelest, Morrisville, PA) in 95% acetone for 1 h. The slides were
washed with acetone and then cured at 110C overnight. The slides were
sterilized with 70% ethanol, and then a thin layer of PEG hydrogel solution
(150 mL) with linear or cyclic RGD peptide was added, evenly covering the
surface. The hydrogels were allowed to cross-link overnight in a humidiﬁed
37C incubator and then were washed in excess PBS for 24 h. Cells seeded
onto RGD/PEG-OVS/albumin hydrogels at 1000–2000 cells/cm2 were
allowed to spread for 6 h in complete growth medium. The slides were
placed into a ﬂow chamber, with attention to minimizing any time without
medium on the cells. The ﬂow chamber consisted of two optically clear
acrylic sheets. Before assembly, the ﬂow chamber was sterilized with 70%
ethanol, and the tubing and medium reservoirs were autoclaved. The PEG-
coated slide was placed into the center of the bottom acrylic sheet. A silicone
gasket was placed on the top acrylic sheet aligned with the glass slide. The
two halves were then screwed together. Each end of the ﬂow area deﬁned by
the silicone gasket had an inlet/outlet hole in the top acrylic sheet. The ﬂow
through the chamber was gravity-driven, and a peristaltic pump was used to
recirculate the medium to the reservoir of the closed system. Fifteen
milliliters of HEPES-buffered low serum medium (MCDB 131 with 0.4%
FAF-BSA, 0.1% fetal bovine serum, 1% ABAM, and 10 mM HEPES, pH
7.4) with or without 100 nM S1P was added to the ﬂow chamber and to the
reservoir. The cells were tracked while exposed to 20 dyn/cm2 ﬂuid shear
stress using time-lapse microscopy for 12 h, recording images every 2 min.
Individual cell migration speeds were analyzed manually using ImageJ to
trace the path of each cell over time. The time increment between analyses
was increased to 6 min if cells maintained a straight path in the three
consecutive images. Data was analyzed by analysis of variance (ANOVA)
with Tukey HSD for unequal N post hoc.
Determination of integrin speciﬁcity of
RGD peptides
Fibronectin, serum protein, linear RGD, and cyclic RGD substrates were
tested for integrin speciﬁcity. Fibronectin (1.5 mg/cm2 at 6 mg/mL in PBS)
and serum (150 mL) were coated onto 48-well plates for 2 h at 37C,
followed by two PBS washes. Nonspeciﬁc adhesion was blocked with 1%
BSA for 1 h at 37C, followed by two PBS washes. PEG-OVS/albumin
hydrogels containing 4.12 mM linear RGD or 0.69 mM cyclic RGD were
also coated onto the bottom of 48-well plates. All wells were seeded with
HAEC at 3500 cells/cm2 for 6 h. At the time of plating, the cells were mixed
with blocking antibodies to the b1 (5 mg/mL, mAb13, BD Biosciences,
Franklin Lakes, NJ) and b3 (5 mg/mL, BD Biosciences, VI-PL2) integrin
subunits. The density of cell adhesion on each substrate with the blocking
antibodies was compared to a control without antibodies.
Assay for initial substratum attachment strength
Cell adhesion strengths to linear and cyclic RGD containing hydrogels were
assessed using a centrifugation assay (43,44). PEG hydrogels (75 mL) with
various concentrations of RGD were formed on the bottom of a 48-well
nontreated culture plate. After cross-linking for 24 h, HAEC were seeded
onto the gels at 10,000 cells/cm2 in 500 mL EGM. After allowing the cells to
attach and spread for 6 h, the gels were washed with DPBS. The wells were
ﬁlled to their tops with DPBS and then covered with adhesive sealing tape.
Images were obtained at 43 to quantify the number of cells initially attached
to the hydrogel. The sealed plates were inverted in the centrifuge and spun at
a speciﬁed rotational speed for 5 min to remove the cells from the hydrogels.
The applied detachment force was calculated with the equation F ¼ Vc 3
(sc – sm)3 RCF, where Vc is the volume of the cell (;5000 mm
3, estimated
from the diameters of spherically shaped cells of ;20 mm), RCF is the
relative centrifugal force, sc is the density of the cell (;1.07 g/mL), and sm
is the density of the DPBS (1.02 g/mL). The wells were washed with DPBS
to remove the ﬂoating cells, and then images were acquired at the same
locations as before the centrifugation. The force required to remove 50% of
cells (F50) was interpolated from the data as F50 ¼ ð0:5 y0ÞðF1F0Þðy1y0Þ 1F0;
where y0 and y1 are the percent cell detachments that bracket 50%
detachment and F0 and F1 are the corresponding forces on the cells. The
standard deviation was calculated by propagation of error, i.e.,
DF50 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
@F50
@y0
Dy0
 2
1 @F50@y1 Dy1
 2r
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Calculation of motility parameters
Time-lapse microscopy images were obtained every 2 min for 12 h of
endothelial cell migration on the surface of RGD-containing PEG hydrogels.
The percent of cells remaining on the gels during the course of the
experiment was recorded for each RGD concentration. The projected cell
areas of all cells were determined by manually outlining the cells after 3 h
under 20-dyn/cm2 shear stress. Isolated, spread endothelial cells were
manually tracked for 12 h to obtain xy-coordinate data for the center of each
cell (cells were excluded during cell division). Coordinate data recorded
every 6 min (Dt ¼ 6 min) for all cells in each experiment were saved as
variables for analysis in MATLAB (MathWorks, Natick, MA). At each time
point i, ti ¼ iDt, the mean-squared displacement was calculated using the
overlapping interval method (45). The root mean-square speed of each
individual cell was calculated by dividing the root mean-square displace-
ment for the smallest tracking interval by the length of the smallest tracking
interval (i.e., 6 min). Each cell’s persistence time was determined by ﬁtting
the persistent random walk model given by:
Æd2ðtÞæ ¼ 2S2P½t  Pð1 et=PÞ
by nonlinear least-squares regression analysis, as previously described,
using the manually measured root mean-square speed (45–47). Path lengths
were calculated as the product of speed and persistence time. Random
motility coefﬁcients were calculated as half the product of the squared speed
and persistence time. Data was analyzed by ANOVA with Tukey HSD for
unequal N post hoc.
Directional index of migration
The directional index of migration (DIM) can be used to indicate the extent
of migration in the direction of the ﬂow relative to the speed of the migrating
cell (48). The path length, s, of each cell, and the distance moved in the
direction of ﬂow, xf, were determined at each time point and then summed
for the duration of the experiment (N time points). The DIM was calculated
by dividing the total distance moved in the direction of ﬂow by the total path
length of the cell,
DIM ¼
+
N
i¼1
xf;i
+
N
i¼1
si
:
If a cell migrated against the ﬂow, the DIMwas negative. A mean DIM of
zero would indicate no preference in the direction of migration for the cell
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population. Data was analyzed by ANOVA with Tukey HSD for unequal N
post hoc.
Parameter estimation using a stochastic model
Cell migration was also analyzed as an Ornstein-Uhlenbeck process to
account for the movement of cells due to ﬂuid shear stress, similar to
previously described methods for chemotaxis (49). Simulated cell migration
is deﬁned by three parameters in a stochastic differential equation, a, b, and
g, which describe the magnitude of random ﬂuctuation, the susceptibility
of the cell to random ﬂuctuations, and a directional bias, respectively. The
cell velocity is calculated from the stochastic differential equation
dvðtÞ ¼ bvðtÞdt1 ﬃﬃﬃap dWðtÞ1gdt (49). The continuous-time white noise
process, dW(t), adds random ﬂuctuations in cell velocity to the model. The
directional bias g was set to zero in the direction perpendicular to the ﬂow.
The stochastic equation was solved using a second-order accurate ﬁnite
difference method in MATLAB. The average cell displacements as a
function of time were calculated for 100 solutions to the stochastic equation.
The calculated displacements were optimized to ﬁt the experimental cell
displacement data using the subplex optimization algorithm (50) imple-
mented in MATLAB by Bruce Lowekamp (‘‘subplexm’’), downloaded
from http://www.netlib.org. The optimized parameters a, b, and g were
converted to speed (S), persistence time (P), and DIM for comparison to the
values calculated from the cell tracking experiments using the equations
a ¼ S2P ; b ¼ 1P (49), and DIM ¼ jvss jS ¼ g=bS ¼ gﬃﬃﬃﬃabp ; where jvssj is the cell drift
velocity due to ﬂuid shear stress. For initial values, we calculated a, b, and g
using the values for speed, persistence time, and DIM calculated by the
methods described above.
Immunoﬂuorescent imaging
Round glass coverslips were cleaned with 1 M HCl overnight at 110C and
silanated with 3-mercaptopropyltrimethoxysilane. The slides were sterilized
with 70% ethanol and a thin layer of PEG hydrogel solution (20 mL)
containing 4.12 mM linear RGD or 0.69 mM cyclic RGDwas coated onto the
slides. After polymerization, the slides were seeded with HAEC and grown
for 18 h at 37C in low serum medium, with or without 100 nM S1P. The
cells were ﬁxed in 4% paraformaldehyde in PBS for 30 min at room
temperature. After rinsing three times with PBS for 5 min each, blocking
buffer (1% w/v IgG-free BSA and 3% normal goat serum in PBS) was added
to the cells for 20 min at room temperature. The cells were incubated with
primary antibody for vinculin (Sigma) or pY397-FAK (BioSource Interna-
tional, Camarillo, CA) at 1:250 dilution in blocking buffer overnight at 4C.
Slides were washed four times in PBS, and then incubated with the secondary
antibody (Molecular Probes, Eugene, OR) at 1:400 dilution in PBS for 1 h at
room temperature. Slides were imaged by confocal microscopy.
RESULTS
Cell migration is expected to have a biphasic dependence on
the adhesion strength of cells to the substrate (21,24). We
have previously shown that S1P promotes endothelial cell
migration on PEG hydrogels containing linear RGD peptide
(15). However, it is not known how S1P-induced increases in
endothelial cell migration depend on the adhesiveness of the
substrate. We examined cell adhesion strength and migration
with and without 100 nM S1P in solution on PEG-OVS/
albumin hydrogels that contained various concentrations of
two different RGD-containing peptides. The concentration
of S1P in serum is ;1 mM (51), but the presence of high-
density lipoproteins in plasma reduces the ability of S1P to
interact with its receptors (52). Although it has been shown
previously that endothelial cell migration continues to in-
crease with higher S1P concentrations, e.g., up to 1–5 mM
(14,27,53), concentrations in this range are likely to be
nonphysiological. Thus, 100 nM S1P in low serum medium
was used for the experiments, a concentration that is suf-
ﬁcient to increase endothelial cell migration and FAK
phosphorylation (29,33,54–56).
Integrin speciﬁcity of RGD peptides
The two peptides used were a linear RGD peptide (Ac-
GCGYGRGDSPG) and a cyclic RGD peptide (Ac-GCNAC*
RGDWGC*G). The linear RGD peptide has a binding prefer-
ence for the avb3 integrin over the a5b1 integrin (41,43). Use of
integrin-speciﬁc function-blocking antibodies against b3 and
b1 subunits conﬁrmed that cell adhesion to the linear RGD pep-
tide was mostly dependent on the avb3 integrin (Fig. 1). The
cyclic RGD peptide was originally selected by Koivunen et al.
from a phage display library for its binding to a5b1 integrin
(41). Cell adhesion to PEG hydrogels containing the cyclic
RGD peptide was signiﬁcantly reduced by antibodies to both
the b1 and b3 integrin subunits, with cell adhesion nearly
eliminatedwith the anti-b1 antibody.Without RGD in the PEG
hydrogels, cell adhesion was quite low, with ,6 cells/cm2
remaining on the hydrogel after PBS washing, and these cells
did not spread on the surface.
Cyclic RGD provides stronger cell adhesion
The initial adhesion strengths of endothelial cells to hydro-
gels containing linear or cyclic RGD were determined using
a centrifugation assay. HAEC were allowed to adhere to and
FIGURE 1 RGD peptides show different integrin speciﬁcity. On the con-
trol surfaces, anti-b1 antibody signiﬁcantly inhibited endothelial cell adhe-
sion to ﬁbronectin, whereas anti-b3 antibody inhibited endothelial cell
adhesion to a serum-protein-coated well. On the PEG/albumin hydrogels, ad-
hesion to the linear RGD peptide was inhibited by anti-b3 antibody, whereas
adhesion to the cyclic RGD peptide was signiﬁcantly inhibited by both the
anti-b3 antibody and anti-b1 antibody. *p , 0.05 versus control on same
substrate. **p , 0.005 versus control on same substrate. ***p , 0.0005
versus control on same substrate.
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spread on the hydrogel surfaces for 6 h. The plates were
inverted and centrifuged to apply a detachment force to the
cells. The percent of cells remaining adhered to the
hydrogels after centrifugation for 5 min was measured for
various centrifugal forces (Fig. 2, A and B). The F50 for each
RGD concentration was interpolated from the averaged data
at each centrifugal force (Fig. 2 C). As the concentration of
linear RGD was increased, the F50 increased from ;850 to
1120 pN. Even though lower concentrations of cyclic RGD
were added to the PEG hydrogels, the values of F50 for
cyclic-RGD-containing hydrogels were higher, ranging from
;1090 to 1550 pN. For example, at a concentration of 0.69
mM RGD, the F50 adhesion strength was 928 pN on linear
RGD peptide and 1290 pN on cyclic RGD peptide.
Cell adherence under shear stress is decreased
on cyclic RGD
Human aortic endothelial cell migration was tracked by time-
lapse microscopy on PEG-OVS/albumin hydrogels con-
taining various concentrations of RGD peptide in a gravity-
driven ﬂow chamber. During the course of the 12-h
experiment, some cells were removed from the hydrogel
due to the ﬂuid shear stress (20 dyn/cm2). For linear RGD, a
signiﬁcant loss of cells from the hydrogel surface was only
seen on the lowest linear RGD concentrations (Fig. 3).
Surprisingly, a signiﬁcant loss of cells from the hydrogel
surface was observed on all cyclic RGD concentrations. Even
at the highest cyclic RGD concentration, a loss of ;20% of
the cells was seen over 12 h, whereas ,5% of the cells were
lost at the same concentration of linear RGD. Although cell
division did occur during the 12 h, cell division was not
coincident with cell detachment (data not shown).
Presence of focal adhesions or focal contacts
most prominent on linear RGD
We observed larger, more spread cells that contained more
focal adhesions and focal contacts in cells grown on 4.12-mM
linear RGD (Fig. 4) (the RGD concentration that led to a
maximum cell speed in the absence of S1P) compared with
cells grown on 0.69 mM cyclic RGD (the RGD concentration
that led to the highest cell speed in the presence of S1P).
Although the staining was performed with cells in static con-
ditions, the size difference was also apparent in the projected
cell areas measured after 3 h in ﬂow. On linear RGD peptide,
the mean projected cell area was 3420 6 2878 mm2 without
S1P and 3450 6 1900 mm2 with 100 nM S1P. On 0.69 mM
cyclic RGD, projected cell areas were 1444 6 613 mm2
without S1P and 1471 6 697 mm2 with 100 nM S1P. The
addition of S1P did not change cell size or the size and num-
ber of focal contacts and focal adhesions on either surface.
S1P-induced cell migration is greatest at higher
adhesion strengths on cyclic RGD
Cell positions recorded at each time interval were used to
determine the mean speed for each cell over the 12-h tracking
period. Without S1P, the migration speed of cells on the
hydrogels had a biphasic dependence on the linear RGD
concentration, with maximum cell speed at 4.12 mM linear
RGD (a biphasic response is deﬁned here as a statistically
signiﬁcant increase at a peptide concentration versus both a
higher and lower peptide concentration). This biphasic depen-
dence was expected from past research by DiMilla et al.
(20,21). When 100 nM S1P was added to the medium, a
signiﬁcant increase in cell speed was seen with increasing RGD
FIGURE 2 Centrifugal detachment force in-
creases with RGD concentration in PEG hydrogels.
The percent of endothelial cells remaining on PEG
hydrogels after 5 min of centrifugal force was
measured. The PEG hydrogels contained (A) linear
RGD, or (B) cyclic RGD.Data are means6 standard
deviations. (C) The detachment forces for removal of
50%of the cells (F50) from theRGD-containing PEG
gels was interpolated from the data in A and B. The
F50 increased as the RGD peptide concentration
increased. The attachment strength to cyclic RGD
was higher than on linear RGD at similar concentra-
tions.
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concentration, but a drop in migration speed was not observed
at the highest linear RGD concentrations, 5.5 mM linear RGD
(Fig. 5 A). At the highest linear RGD concentrations,
endothelial cell migration speed more than doubled with the
addition of 100 nM S1P. On cyclic RGD-containing hydrogels
without S1P, the migration speed on the hydrogels did not have
a statistically signiﬁcant dependence on the peptide concentra-
tion (Fig. 5 B). The addition of 100 nM S1P dramatically
increased the endothelial cell migration speed, particularly at
the higher cyclic RGD concentrations. Migration speed with
S1P peaked at 0.69 mM cyclic RGD. At this cyclic RGD
concentration with S1P, the cell migration speed was more
than twice the speed of cells without S1P, and 44% greater than
the highest migration speed seen on linear RGD with 100 nM
S1P.
Cell attachment strengths at the lowest concentrations of
cyclic RGD were comparable to the highest concentration of
linear RGD peptide, allowing us to combine the data into a
plot of cell speed over a wide range of cell adhesion strengths
(Fig. 6). The relatively good agreement between cell
migration speeds found for linear and cyclic RGD peptides
with similar adhesion strengths is surprising given the tre-
mendous difference in morphology and focal adhesion den-
sity between the cells on the different peptides.
Persistence time weakly affected by S1P
or RGD concentration
The persistence time was determined for each cell by ﬁtting
the calculated root mean-squared speed to the persistent
random-walk displacement equation. The persistence times
were greater on 4.12 mM linear RGD than on 0.69 or 1.38
mM linear RGD in the absence of S1P (Fig. 5 C). With 100
nM S1P, persistence time was not signiﬁcantly changed by
RGD peptide concentrations except at the highest linear
RGD concentration tested (5.5 mM). On the cyclic-RGD-
containing hydrogels in the absence of S1P, the persistence
time did not depend on RGD concentration (Fig. 5 D). With
100 nM S1P, persistence times showed an increase at the
lowest cyclic RGD concentration tested (0.34 mM).
FIGURE 3 Cell adherence to RGD-containing PEG hy-
drogels under shear stress. The percent of endothelial cells
remaining on the gels during the 12-h ﬂow experiment
increasedwith increasing peptide concentration.Greater than
50% cell loss was found for the lowest (0.34 mM) linear and
cyclic RGD concentrations. Cell loss was 25–30% on 0.69
mM cyclic RGD, where the maximum migration speed was
observed.
FIGURE 4 RGD peptide effects on focal adhesion/focal
contact formation. The extent of focal adhesion formation
on 4.12-mMlinear and 0.69-mMcyclicRGDwasmeasured
by immunoﬂuorescence staining for pY397-FAK (A–D) and
vinculin (E–H). On 4.12-mM linear RGD, staining was
localized to sites of adhesion in the absence (A and E) and
presence (B and F) of 100 nM S1P. On 0.69-mM cyclic
RGD, vinculin and pY397-FAKstainingwasweak at the cell
periphery and cells were generally smaller than on linear
RGD (C and G, no S1P; D andH, 100 nM S1P). Black and
white images were inverted in Image J to highlight staining.
A color version of this ﬁgure containing additional cells is
included in Supplementary Materials, Fig. S2.
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S1P may increase the directional index
of migration
High levels of ﬂuid shear stress, as would be present in
arteries, have been shown to promote endothelial cell
migration in the direction of ﬂow (57–61). The DIM was
calculated by dividing the total distance moved in the
direction of ﬂow by the total path length of the cell. The DIM
can be used to indicate the extent of migration in the
direction of the ﬂow relative to the speed of the migrating
cell. A negative value would indicate cell migration against
the ﬂow, whereas a value of zero indicates random motility,
as would be expected without directional stimuli such as
ﬂow.
The DIM was calculated for endothelial cell migration on
both linear and cyclic RGD, with and without 100 nM S1P
under 20 dyn/cm2 of shear stress. Endothelial cells prefer-
entially migrated in the direction of ﬂow under all condi-
tions. On linear RGD, the mean DIM ranged from 0.24 to
0.64 (Fig. 7). Although no signiﬁcant increase due to S1P
was observed at any single linear RGD concentration, S1P
did cause a signiﬁcant increase in the directional migration of
the endothelial cells, combining data for all linear RGD
concentrations. On cyclic RGD, the DIM ranged from 0.23
to 0.75. The addition of S1P did not signiﬁcantly alter the
DIM on cyclic RGD (Fig. 7).
Biphasic random motility coefﬁcient in the
absence of S1P
Together, cell speed and persistence time determine the
motility characteristics of individual cells. A random motility
coefﬁcient, m, can be calculated from the speed and
persistence time using the equation m ¼ S2Pn ; where n is the
dimension of migration. The random motility coefﬁcient,
corresponding to the coefﬁcient of molecular diffusion,
FIGURE 5 Cell speed and persistence time on PEG
hydrogels with linear and cyclic RGD peptides in the
presence of ﬂuid ﬂow. Individual cell speeds were found
by dividing the displacement at the shortest time interval
by the length of the time interval (i.e., 6 min). (A) Cell
speed was biphasic on linear RGD without S1P, and was
increased by S1P, particularly with 5.5 mM RGD *p ,
0.05 versus no S1P, 0.69, 1.38, 2.75, and 5.5 mM linear
RGD. **p , 0.05 versus no S1P, 0.69 mM linear RGD.
(B) S1P increased cell speed for all cyclic RGD concen-
trations and a maximum cell speed was found for 0.69 mM
RGD. yp , 0.05 versus no S1P, 0.52 and 1.38 mM RGD.
(C) Persistence time was not strongly dependent on linear
RGD concentration. #p , 0.05 versus no S1P, 0.69 and
1.38 mM linear RGD. ##p , 0.05 versus no S1P, 0.69 and
1.38 mM linear RGD and 100 nM S1P, 1.38 and 4.12 mM
linear RGD. (D) S1P may increase the persistence time at
low concentrations of cyclic RGD. zp , 0.05 versus no
S1P, 0.52 mM cyclic RGD and 100 nM S1P, 1.38 mM
cyclic RGD. Data are means 6 95% conﬁdence interval
based on the mean 6 SE. Please conﬁrm. Analysis by
ANOVA with Tukey HSD for unequal N post hoc.
FIGURE 6 Cell speed related to initial attachment strength on linear and
cyclic RGD in the presence of ﬂuid ﬂow. Cell speed on PEG hydrogels with
linear and cyclic RGD peptides was affected by the initial strength of cell
attachment to each gel. The linear and cyclic RGD results from Fig. 5 seem
to overlap, indicating the importance of cell adhesion strength in determin-
ing cell speed. Without S1P, two maxima in migration speed are present, at
1020 and 1290 pN attachment strength. In the presence of 100 nM S1P,
migration speed continues to increase from the linear RGD to the cyclic
RGD attachment strength ranges. yp, 0.05 versus linear RGDwithout S1P,
930 pN. yyp , 0.05 versus linear RGD with S1P, 850 and 970 pN, linear
RGD without S1P, 930, 970, 1000, and 1110 pN, and cyclic RGD without
S1P, 1140 pN. yyyp , 0.05 versus linear RGD with S1P, 850 and 970 pN,
linear RGD without S1P, 930, 970, 1000, and 1110 pN, and cyclic RGD
without S1P, 1140 and 1540 pN. *p, 0.05 versus linear RGD without S1P,
930, 970, and 1110 pN, and cyclic RGD without S1P, 1140 pN. **p, 0.05
versus linear RGD without S1P, 930 pN. Data are means6 95% conﬁdence
interval based on mean 6 SE. Analysis by ANOVA with Tukey HSD for
unequal N post hoc.
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quantitatively describes the random migration of the cell
population. Without S1P, m shows a biphasic dependence on
the initial adhesion strength, displaying a single maximum at
1020 pN with linear RGD (Fig. 8). The random motility
coefﬁcient increased with the addition of 100 nM S1P to the
medium, in some cases dramatically, but was associated with
large variances. At an adhesion strength of 1290 pN, the
mean random motility coefﬁcient increased 13.8-fold upon
addition of S1P.
Cell speed related to projected cell area
The projected area of each spread cell was measured after 3 h
under 20 dyn/cm2 of shear stress. Without S1P, the mean cell
area increased as the linear RGD concentration increased,
but with the addition of 100 nM S1P, the mean cell areas
were not signiﬁcantly inﬂuenced by RGD concentration
(data not shown). Examining the mean cell speeds as a
function of the mean cell areas on linear RGD revealed no
obvious relationship, with or without S1P. To further dissect
how the cell area is related to cell speed, we split the cell
areas into quartiles. The cell area quartiles were determined
using cells on all linear RGD gels without S1P, to examine
the full range of cell areas. In the absence of S1P, the cell
speeds were not signiﬁcantly different for cells in different
cell-area quartiles (Fig. 9 A). When the cells were supplied
100 nM S1P, cell speeds were signiﬁcantly greater for
smaller cells compared to larger cells. Small cells also dem-
onstrated a signiﬁcantly greater migration speed in the
presence of S1P than without it.
For PEG hydrogels with cyclic RGD peptide, a trend
toward larger projected cell areas at higher RGD concen-
trations was observed, although the difference was not
signiﬁcant. S1P did not change this trend. We examined the
relationship between cell speed and cell area on the cyclic
RGD gels. In the absence of S1P, no signiﬁcant differences
were observed (Fig. 9 B). When 100 nM S1P was added to
the cells, the cell speed was signiﬁcantly increased for cells
with areas 0–1522 and 2288–3519 mm2.
Stochastic modeling analysis
An alternative method of analyzing cell migration is to ﬁt
experimental cell displacements to simulated cell displace-
ments over different time intervals, which allows a straight-
forward accounting of biased cell migration in the presence
of ﬂow. Stochastic cell migration is modeled here by three
parameters, a, b, and g, which describe the magnitude of
random ﬂuctuations, susceptibility of the cell to random
ﬂuctuations, and a directional bias, respectively (49). Ran-
dom ﬂuctuations in migration were modeled as a continuous
white-noise process, and the stochastic differential equation
was solved numerically, varying a, b, and g to achieve a
nonlinear least-squares ﬁt with the cell displacement data.
The parameters a, b, and g were converted to speed, per-
sistence, and directional index of migration for comparison
to values calculated from the cell tracking experiments using
the persistent random walk method (Fig. 10). We found an
excellent agreement for the two methods in calculating the
root mean-square cell speed (r ¼ 0.97) and marginal agree-
ment with persistence time and the squared DIM (r ¼ 0.54
and 0.47, respectively). The squared DIMs were compared
FIGURE 7 Directional index of migration of PEG hydrogels with RGD
peptides in the presence of ﬂuid ﬂow. The DIM represents the fraction of cell
displacement that is in the direction of ﬂow. DIM does not strongly depend
on the adhesion strength for either linear or cyclic RGD. *p , 0.05 versus
linear RGD with S1P, 1110 pN initial adhesion strength. However,
combining data for all concentrations of each RGD peptide, S1P caused a
signiﬁcant increase in DIM on linear RGD. Data are means 6 95%
conﬁdence interval based on mean6 SE. Analysis by ANOVA with Tukey
HSD for unequal N post hoc.
FIGURE 8 The cell random motility coefﬁcient is highest in the presence
of 100 nM S1P. Random motility coefﬁcients were calculated from the cell
speeds and persistence times in Fig. 5. The random motility coefﬁcient
increased with 100 nM S1P and peaked at a higher adhesion strength when
S1P was added. *p, 0.05 for linear RGDwithout S1P, 1020 pN versus 930,
970, and 1000 pN, and cyclic RGD without S1P, 1140 and 1540 pN. **p,
0.05 versus linear RGD without S1P, 930 and 970 pN. Data are means 6
95% conﬁdence interval based on mean 6 SE. Analysis by ANOVA with
Tukey HSD for unequal N post hoc.
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because positive and negative values for g are equivalent by
this method.
DISCUSSION
Our PEG hydrogel materials are formed by cross-linking
PEG-OVS with BSA. We have previously demonstrated that
due to the lipid-binding abilities of albumin, S1P can be
trapped in these hydrogels and delivered in a controlled
manner (15). These S1P-releasing materials produced a
strong angiogenic response in the chick chorioallantoic
membrane assay and increased the migration speeds of
human umbilical vein endothelial cells attached to the S1P-
releasing hydrogels containing linear RGD peptides. Given
the clinical utility of PEG materials as compared with other
hydrogel materials used in cell adhesion and migration
studies, we believe that the results generated with this system
may be more readily applied to the development of coatings
for endovascular stents and vascular grafts. As such, all of
the migration experiments in this study were performed with
human aortic endothelial cells in the presence of arterial
levels of ﬂuid shear stress.
The migration rates of endothelial cells are greatly in-
ﬂuenced by chemical and physical interactions with the sub-
strate. Experimental and theoretical results suggest that the
migration rates of cells have a biphasic dependence on the
strength of the cell’s attachment to the substrate (20–23). Yet
the circumstances under which cell adhesivity can be used to
predict migration speeds are limited (21,24,34). Adhesion
strength may control migration if other factors are kept
constant, but if other stimuli are added, such as growth factors
that affect signaling processes of the cell, the migration/
adhesion relationship can be dramatically altered (34). More
recent research from Waterman-Storer et al. has suggested
that a balance between the activities of actin, myosin II, and
focal adhesion dynamics determine cell migration speeds, and
that cell adhesion strength is only one factor that contributes to
the dynamic interactions between these proteins (63).
Our data demonstrated that initial cell attachment strengths
at the lowest concentrations of cyclic RGD were comparable
FIGURE 9 Higher cell speeds across a range of
cell areas on cyclic RGD in the presence of 100 nM
S1P. Mean cell speeds by cell area quartiles are
shown for endothelial cellsmigrating on: (A) linear or
(B) cyclic RGD peptide. *p , 0.05 versus all other
cell area quartiles on linear RGD with and without
S1P. **p , 0.05 versus no S1P, 0-1522 and 3519–
20000mm2 cells on linear RGD. zp, 0.05 versus no
S1P, 0–1522, 1522–2288, and 2288–3519mm2 cells
on cyclic RGD. Data are means 6 95% conﬁdence
interval based on mean6 SE. Analysis by ANOVA
with Tukey HSD for unequal N post hoc.
FIGURE 10 Quantifying cell migration parameters us-
ing a stochastic model. Cell displacements on PEG
hydrogels containing linear or cyclic RGD peptides were
nonlinear least-squares ﬁt to numerical solutions of an
Ornstein-Uhlenbeck equation, as described in Methods.
The RMS cell speeds, persistence times, and DIMs were
determined. Each of the values derived from the stochastic
model was compared to the manually measured values
(speed and DIM) or least-squares ﬁt (persistence time). (A)
The stochastically measured cell speed had a Pearson
correlation coefﬁcient of 0.97 with the measured RMS cell
speed. (B) The correlation coefﬁcient for cell persistence
time was 0.54. (C) The DIM squared had a correlation
coefﬁcient of 0.46.
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to those at the highest concentrations of linear RGD.
Comparing the cell migration speeds on cyclic and linear
RGD surfaces as a function of initial cell attachment strength
(Fig. 6), the cyclic RGD migration speeds in the presence of
S1P appeared to be a relatively smooth extension of the linear
RGD migration speeds. However, the combined results in the
absence of S1P seem to show two peaks in migration speed,
one for each peptide. In principle, very low migration speeds
should have been observed at all cyclic RGD concentrations
in the absence of S1P due to the high strength of adhesion to
this peptide. Although this was not observed for cell migration
speeds, this pattern was observed for the random motility
coefﬁcient in the absence of S1P. This resulted from the
presence of what appeared to be a biphasic persistence time on
linear RGD in the absence of S1P, and an inverted biphasic
persistence time on cyclic RGD in the absence of S1P. Staining
for vinculin and focal adhesion kinase demonstrated differ-
ences in the organization of focal adhesions and in cell
spreading between linear and cyclic RGD surfaces. If the same
underlying machinery for cell locomotion is present in cells on
both surfaces, then focal adhesions and focal contacts might
be seen as a hindrance to the most rapid rates of cell migration.
On cyclic RGD, cells may migrate more rapidly because
they are not limited by the presence of focal adhesions, whose
disassembly is necessary for cell migration. An Ezrin-mediated
migration mode has been observed with cells in 3D culture
(64), but we did not determine if cell migration on the cyclic
RGD was noncanonical.
Long-term adhesion of endothelial cells to the cyclic RGD
peptides in the presence of arterial levels of wall shear stress
(20 dyn/cm2) was worse compared to that with linear RGD
peptides. This was despite higher initial attachment strengths
to the cyclic RGD hydrogels. This effect may be biome-
chanical, due to the higher proﬁle in the ﬂow and fewer focal
adhesions. Cells growing on 1.38 mM cyclic RGD peptide
had similar projected cell areas to cells growing on 1.38 mM
linear RGD. However, projected cell areas were reduced at
lower cyclic RGD concentrations. A less spread cell could
have a greater contact angle with the surface that would alter
the hemodynamic force applied to the cell (65).
Both the avb3 and a5b1 integrin are highly expressed in
endothelial cells (66–69). Although integrin surface densities
have not been reported for HAEC, a5b1 expression in HUVEC
has been reported to be;7.53 105 receptors per cell (68). The
expression of avb3 and a5b1 has been reported to be altered by
shear stress. In HUVEC, mRNA and cell surface expression of
a5b1 was reportedly increased by shear stress, whereas avb3
expression was unchanged (70). In bovine aortic endothelial
cells, avb3 and a5b1 integrin cell surface density were both
increased by exposure to shear stress, although upregulation
required the engagement of the respective integrin on the
substrate (71). However, in HAEC, it was reported that a5b1
mRNA expression was decreased by laminar shear stress after
24 h, whereas avb3 mRNA expression was unchanged (72). If
a5b1 expression were decreased by shear stress in HAEC in our
12-h experiments, this could explain the loss of cells on the
cyclic RGD during tracking, presuming that the b1 integrin
binding was primarily associated with a5b1.
In addition to changes in the cell surface expression of
integrins, the afﬁnities of integrins are also dynamic (73).
Both avb3 and a5b1 integrins can undergo afﬁnity matura-
tion, causing the recruitment of avb3 to focal adhesion in the
cell periphery and lamellipodia (74,75), whereas a5b1
remains in ﬁbrillar adhesions with no change in localization
(74). Shear stress induces high-afﬁnity avb3 in endothelial
cells and focal adhesion formation (71,76). High-afﬁnity a5b1
binding to ﬁbronectin creates ﬁbrillar adhesion, which requires
a synergistic syndecan PHSRN binding site for maturation
(77–79). The induction of high-afﬁnity avb3 integrin and
focal adhesions on the linear RGD, and the absence of matu-
ration on the cyclic RGD due to absence of binding to the
synergy site on a5b1 could also explain the differences in
long-term cell adherence between the two peptides in the
presence of ﬂuid shear stress. However, we did not speciﬁ-
cally identify the b3 integrin as avb3 nor the b1 integrin as
a5b1, so other integrin a-subunits may also contribute to the
observed results.
Many factors other than adhesion strength could play a
role in the cell migration speed. As noted earlier, it has been
suggested that focal adhesion and cytoskeletal dynamics
could change the relationship of migration to cell attachment
strength (63). Shear stress has been shown to affect endothe-
lial cell migration through a variety of mechanisms involving
integrins (70,80–82). The increase in cell migration speed
induced by shear stress has been attributed entirely to the a5b1
integrin (83). S1P has been shown to stimulate the phosphor-
ylation of focal adhesion kinase (29) and cause remodeling of
focal adhesions in endothelial cells (35,84). This could alter
cytoskeletal dynamics and change the effect of cell adhesion
strength on migration speed.
Growth factors and other chemotactic/chemokinetic
agents also affect the dynamics of actin and myosin in the
cell. Activation of Rac by S1P, vascular endothelial growth
factor (VEGF), or basic ﬁbroblast growth factor (bFGF)
results in increased lamellipodia formation and subsequent
localization of Rac activity to the leading edge of the cell
(75,85,86). Rac promotes lamellipodia extension via actin
polymerization induced by activatingWAVE proteins (85,87).
High-afﬁnity avb3 integrin is recruited to the leading edge
by Rac, promoting the formation of new adhesions that
stabilize the lamellipodia (75). Rac activation by VEGF and
bFGF is PP2-sensitive and thus Src-dependent (86,88). S1P-
inducedmigration does not require Src, but does depend on the
on Akt-mediated phosphorylation of its S1P1 receptor (88).
Lamellipodia extension promoted by S1P or VEGF requires
phosphatidylinositol-3 kinase activity, whereas bFGF-induced
lamellipodia formation does not (88). This suggests that al-
though the chemotactic factors promote migration via Rac
activation, cytoskeletal dynamics are altered through several
independent pathways.
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The results of the stochastic model generally agreed with
the manual measurements, but highlight some of the
difﬁculties in calculating two or three parameters using
mean-squared displacement data. For least-squares ﬁtting of
the data to the stochastic model, we used as initial values the
speed and persistence times previously calculated without
considering cell drift. Considering the sensitivity of the
mean-squared displacement to cell speed and persistence
time (@Æd2æ/@S and @Æd2æ/@P, respectively, of the equation
Æd2ðtÞæ ¼ 2S2P½t  Pð1 et=PÞ), the mean-squared dis-
placement is ;100 times more sensitive to changes in the
persistence time at values of the variables relevant to our
system (e.g., S ¼ 30 mm/h, P ¼ 10 min with 1-h time steps).
Therefore, it is not surprising that the minimization routine
reduced the persistence time and not the cell speed to account
for the cell drift. However, values of the absolute value of
DIM calculated with the stochastic model were lower than
the manual measurement. Given the reduction in persistence
time with the stochastic model, it is possible that cell turning
was present at time steps ,6 min, increasing the cell speed
and path length and decreasing the actual DIM. This should
not affect the trends observed in the data but would impact
the reported magnitudes.
Overall, our results indicate that the peak in cell migration
speed and random motility coefﬁcient is either eliminated or
shifted to higher adhesion strengths in the presence of S1P.
The magnitude of the maximum cell migration speed is
increased by as much as 13.8-fold with the addition of
100 nM S1P. These effects may be due to more efﬁcient
lamellipodia formation via enhanced Rac activation and an
increase in cell contractility due to localized RhoA activation
in the trailing edge of the cell. Using the terms in the model
by Dimilla et al. (20), we propose that C, the ratio of
uropodal to lamellipodal adhesiveness, is decreased, whereas
fc, the intracellular contractile force, is increased with the
addition of 100 nM S1P. We suggest that experimental
perturbations of S1P1 phosphorylation, Rac activation, and
myosin contractility may differentiate between lamellipodal
adhesiveness and intracellular contractility in S1P-enhanced
migration on RGD peptides.
CONCLUSIONS
Using single-cell tracking, we showed that S1P caused a
signiﬁcant increase in endothelial cell migration speeds on
PEG hydrogels with linear and cyclic RGD peptides in the
presence of ﬂuid ﬂow. The fastest migration speeds with S1P
were found on the cyclic RGD peptide-containing hydrogels.
S1P promoted rapid cell migration at RGD peptide concen-
trations that restricted cell migration without S1P. With S1P
altering the biphasic relationship between cell adhesion and
migration, a cyclic RGD concentration was found that
promoted high rates of endothelial cell migration and high
initial cell adhesion to the hydrogels. However, the endo-
thelial cells on the cyclic RGD displayed a decrease in cell
adherence in ﬂow compared to linear RGD. To achieve ﬁrm
adhesion in the presence of ﬂow similar to that in in vivo
conditions, it is possible that mixtures of different adhesion
peptides will be beneﬁcial, binding multiple integrins to
allow both rapid cell migration in the presence of S1P and
high long-term adhesion strengths in ﬂow.
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